posted on Jun, 25 2004 @ 05:08 AM
Shares in Crucell, a small Dutch biotechnology company, jumped on Friday morning after the group announced it had discovered an antibody for
protection against the Sars virus.
Results of the company's study, which involved testing the antibody in ferrets, will be published in The Lancet medical journal on Saturday.
This just hours from when the successful testing of a Sars vaccine was announced by U.S. National Institute of Allergy and Infectious Diseases.